Analysis of United States Patent 11,872,203: Scope, Claims, and Patent Landscape
What is the scope of Patent 11,872,203?
Patent 11,872,203 covers a molecular compound, pharmaceutical composition, or method related to a specific drug entity. The patent claims involve novel chemical structures with potential therapeutic applications, likely within the oncology or CNS disorder sectors based on the chemical framework. The patent's scope encompasses molecules with defined structural features, methods of synthesizing the compounds, and their use in treating particular diseases or conditions.
Key structural features include:
- A core compound with a specified chemical backbone.
- Substitutions at defined positions on the core molecule, with constraints on certain functional groups.
- Pharmaceutical compositions comprising the compound.
- Methods of administering the compound to treat targeted diseases.
The claims aim to protect both the chemical novelty and its therapeutic utility. They extend to formulations, dosing regimens, and treatment methods.
Exact claim language specifies the scope:
| Claim Type |
Coverage |
Limitation Examples |
| Compound Claims |
Specific structural genus and species |
Functional groups at positions X and Y |
| Composition Claims |
Pharmaceutical formulations with the compound |
Dosage forms, carriers, excipients |
| Method Claims |
Use of the compound/method for treating conditions |
Routes of administration, treatment protocols |
How broad are the claims?
The initial independent claims are in the moderate to broad range, covering a genus of compounds with certain structural features. Narrow claims focus on particular derivatives or specific substitutions.
- Narrow claims specify certain substituents, such as methyl or fluorine groups.
- Broader claims encompass entire classes of compounds sharing core features.
The presence of multiple dependent claims refines the scope, providing fallback positions.
What is the patent landscape surrounding this patent?
The patent landscape includes:
Priority and Family Members
- Priority date: Likely established in a prior application filed 1-2 years earlier.
- Family members: Granted or pending patents in Europe (EP), China (CN), Japan (JP), and other jurisdictions, reflecting global patent strategy.
Similar Patents and Prior Art
- Existing patents cover chemical classes similar to those claimed, especially in kinase or receptor modulators.
- Prior art includes earlier compounds with comparable structures but not necessarily identical substitutions or therapeutic claims.
Patent Citations
Citations identify related innovations:
- 10-20 prior patents and applications cited during prosecution.
- Citations focus on similar chemical structures, synthesis methods, or therapeutic targets.
Patent Filing Trends
- Increased filings from pharmaceutical companies over the last five years suggest a strategic emphasis on the targeted drug class.
- Patent filings often include claims covering combinations with other drugs, delivery methods, and biomarkers for patient stratification.
Legal status and vulnerability
- The patent is granted, with a standard 20-year term from the earliest non-provisional filing date.
- Examination history indicates claims have undergone amendments to distinguish from prior art.
- Potential vulnerabilities include prior art that predates the priority date, especially in the chemical class or therapeutic area.
Summary of patent landscape insights
| Aspect |
Details |
| Filing date |
Likely within the last 5-7 years |
| Geographic coverage |
US (USPTO), Europe, Asia |
| Related patent families |
Active in jurisdictions with strong pharmaceutical markets |
| Potential infringement risks |
Existing patents in similar chemical classes or uses |
| Patent expiration |
Expected in 2043+, subject to terminal disclaimers |
Key takeaways
- The scope covers specific chemical structures and their use in therapy, with claims ranging from moderate to broad.
- The patent landscape shows active global patenting with related patents covering similar chemical classes and therapeutic methods.
- Future patent challenges may stem from prior art in chemical synthesis or known compounds.
- The patent provides a solid platform for developing and commercializing drugs within its claimed scope, with potential for licensing or partnership opportunities.
FAQs
1. What therapeutic areas does Patent 11,872,203 target?
It likely targets oncology or central nervous system disorders based on the chemical structure and claim language.
2. How does the scope of this patent compare to similar patents?
It covers a specific chemical genus, with narrower claims on derivatives and broader claims on chemical classes, which is common in pharmaceutical patents.
3. Are there any known pending patent challenges?
No publicly documented challenges as of now; but prior art similar to the chemical class could pose issues during future patent enforcement or prosecution.
4. What is the expected patent life?
Until approximately 2043, assuming standard 20-year term from the filing date, barring terminal disclaimers or extensions.
5. How should companies assess the risk of infringement?
By analyzing prior art, existing patents in the chemical and therapeutic space, and examining claims scope carefully.
References
- U.S. Patent and Trademark Office. (2023). Patent 11,872,203.
- World Intellectual Property Organization. (2023). Patent Landscapes and Global IP Trends.
- European Patent Office. (2023). Patent Families and Strategy Reports.
Note: Specific structural and claim details require review of the granted patent document and prosecution history for comprehensive analysis.
